How do you pay?

How to pay the least

Ask for the cash price

NYPOZI txid

NYPOZI txid is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

What to do

  1. Ask your pharmacy for NYPOZI txid’s cash price, and one or two other pharmacies too.

Compare every option

Brand name

NYPOZI txid, the original

Cash priceAsk the pharmacy

We didn’t find a savings card or cash price from NYPOZI txid’s maker. Ask the pharmacy for NYPOZI txid’s cash price. With insurance, ask what your plan charges.

Authorized generic

There isn’t one.

Not soldThere isn’t one

Regular generic

NYPOZI txid is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

Not soldAsk the pharmacy

What it’s used for

What the FDA label says

NYPOZI is a leukocyte growth factor indicated to:

  • Decrease the incidence of infection, as manifested by febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a significant incidence of severe neutropenia with fever
  • Reduce the time to neutrophil recovery and the duration of fever, following induction or consolidation chemotherapy treatment of patients with acute myeloid leukemia (AML)
  • Reduce the duration of neutropenia and neutropenia-related clinical sequelae, e.g., febrile neutropenia, in patients with nonmyeloid malignancies undergoing myeloablative chemotherapy followed by bone marrow transplantation (BMT)
  • Mobilize autologous hematopoietic progenitor cells into the peripheral blood for collection by leukapheresis
  • Reduce the incidence and duration of sequelae of severe neutropenia (e.g.‚ fever‚ infections‚ oropharyngeal ulcers) in symptomatic patients with congenital neutropenia‚ cyclic neutropenia‚ or idiopathic neutropenia
  • Increase survival in patients acutely exposed to myelosuppressive doses of radiation (Hematopoietic Syndrome of Acute Radiation Syndrome)

Source: the FDA label for NYPOZI txid (Tanvex BioPharma USA, Inc.), January 15, 2026. Full label on DailyMed 

Good to know

  • We didn’t find a savings card from NYPOZI txid’s maker.
  • Don’t stop or change a medicine without talking to your pharmacist or prescriber.